📰 Epigenetic Reprogramming News
Page 2 - Epigenetic Reprogramming News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Epigenetic Reprogramming. Real-time updates on events, politics, business and more.
January 24, 2023
The Business Research Companys Nucleic Acid Based Gene Therapy Global Market Report 2023 – Market Size, Trends, And Global Forecast 2023-2032
November 1, 2022
/PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF), the nations leading pulmonary fibrosis research, advocacy, and education organization, has announced...
October 24, 2022
/PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today presents...
September 30, 2022
/PRNewswire/ -- Turn Biotechnologies Co-founder and Head of Research Vittorio Sebastiano today will present at the Mechanisms of Aging Meeting taking place at...
September 13, 2022
The proprietary platform is versatile, equally effective with different cargoes, routes of administration
August 22, 2022
Albert Wu, MD, PhD, a recognized advocate of using stem cell therapy to treat eye conditions, will advise company's development of ocular tissue
August 8, 2022
Vittorio Sebastiano, globally recognized for pioneering science, expands his role at company he co-founded as it moves closer to clinical research MOUNTAIN VIEW, Calif., Aug. 8, 2022 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that co-founder Vittorio Sebastiano, PhD, will become its head of research. Sebastiano led development of the unique mRNA-based ERA (Epigenetic Reprogramming ...
April 13, 2022
/PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) and Daewoong Pharmaceutical (KRX: 069620.KS) today announced expansion of their open collaboration strategy...
April 11, 2022
Press release content from PR Newswire. The AP news staff was not involved in its creation.